表紙
市場調査レポート

ヘモグロビンA1cモニタリングの世界市場

Hemoglobin A1c Monitoring

発行 Global Industry Analysts, Inc. 商品コード 121098
出版日 ページ情報 英文 266 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
ヘモグロビンA1cモニタリングの世界市場 Hemoglobin A1c Monitoring
出版日: 2016年05月01日 ページ情報: 英文 266 Pages
概要

当レポートでは、ヘモグロビン(Hb)A1cモニタリングの世界市場に注目し、2012-2020年の期間を対象に総取引価額の推移を製品種(HbA1cラボ試験、HbA1cポイントオブケア試験)および地域(米国、カナダ、日本、欧州、アジア太平洋州、中南米、その他)別に検証・予測するほか、過去7年間の市場経緯についての分析や大小参入企業27社のプロフィールなど競合環境についての調査情報をまとめて、概略以下の構成でお届けします。

第1章 イントロダクション、調査方法、製品の定義

  • 調査の信頼性とレポートの限界
  • 免責事項
  • データの解釈とレポート作成レベル
    • 定量技法と分析
  • 製品の定義と調査範囲
    • HbA1cラボ試験
    • HbA1cポイントオブケア試験

第2章 エグゼクティブサマリー

  • 市場概要
    • 概略基礎知識
    • 主な問題点
    • 糖尿病患者数の増大 - 主要な成長材料
    • 急速な老齢化と増大する糖尿病人口:主な推進要因
    • 市場成長の背景にある肥満度の高まり
    • 開発途上国:今後の成長機会
    • 新興市場における医療支出の増大
    • 開発途上国向け製品ライン拡充に向かう製造業
    • 定着するベッドサイド検査
    • 心臓リスクを遠ざける定期HgA1c検査
    • 糖尿病診断:HgA1c検査の機会
    • HgA1c検査を診断目的に推奨することは正しいか
    • グリコシル化血色素試験:早期糖尿病診断への地歩を固めるもの
    • 技術開発で急展開する糖尿病診断
    • ポイントオブケア試験:店舗販売の積極的機会
    • 複合的競合環境が支配するポイントオブケア診断市場
    • ポイントオブケアHgA1c検査:ラボ試験に対して大きな優位性
    • ポイントオブケアHgA1c検査の主な検査手法
    • 免疫測定
    • ボロン酸アフィニティークロマトグラフィ
    • マイクロ光学検出
    • 在宅モニタリング:付きまとう精度問題
    • 糖化アルブミン - HgA1c検査を脅かす可能性は?
    • グリコシル化血色素のレベル上昇とともに高まる死のリスク
    • HgA1c検査市場を脅かす無侵襲性血糖値計とカンナビゲロールモノエチルエーテル混合(CBGM)装置
    • 欧州心臓病学会(ESC)と米国糖尿病協会(ADA)がHgA1c検査の改訂ガイドラインを発表
    • 競合環境
  • 糖尿病 - 疾患の輪郭
    • 糖尿病の原因
    • 糖尿病の種類
    • 糖尿病の主な種類
    • 想定できる合併症
    • 腎症
    • 糖尿病性神経障害
    • 網膜症
    • 感染症や創傷の治癒不良
    • 男性の性的不能
    • 歯周病
    • 心疾患
    • 糖尿病の重要統計数値を寸見する
    • 世界各地の糖尿病患者数
    • 糖尿病治療の選択肢
    • 2型糖尿病に対する経口薬
    • インスリン治療の副作用
    • 7%未満のHgA1c試験結果を維持する
    • 一般的な糖尿病管理手順
  • 製品概要
    • ヘモグロビン - 概説
    • ヘモグロビンA1c - 解説
    • HbA1cモニタリング
    • A1cとは
      • 1. HbA1cラボ試験
      • 2. HbA1cポイントオブケア試験およびセルフモニタリング
    • ヘモグロビンA1c試験
    • HbA1c測定数値の解釈
    • HbA1c試験結果
    • HbA1c試験の臨床利用
    • HbA1c評価・解釈の優位点
    • HbA1c試験をめぐるリスク
    • グリコヘモグロビンの測定方法
    • HbA1c試験を選択する理由
    • 血糖コントロールと合併症に関する大規模臨床試験(DCCT)
    • Kumamoto and UK Prospective Studies
    • 糖尿病モニタリングに用いられる血糖検査
    • HbA1c試験の種類
    • HbA1cラボ試験
    • HbA1cポイントオブケア試験およびセルフモニタリング
    • 糖化ヘモグロビン測定の標準化
    • 全米グリコヘモグロビン標準化プログラム(NGSP)のHbA1c基準
    • 国際臨床化学連合(IFCC)のHbA1c基準
    • HbA1c数値の報告方法
  • 製品承認・発売
  • 最近の産業活動
  • 主要参入企業
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他の国々
  • アジア太平洋州
    • 中国
    • インド
    • その他の国々
  • 中南米
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-1218

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 25 companies including many key and niche players such as -

Abbott Laboratories
Alere, Inc.
ARKRAY, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study
    • HbA1c Laboratory Testing
    • HbA1c Point of Care Testing

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • A Quick Primer
  • Growth Stimulants in a Nutshell
  • Major Concerns
  • Increasing Diabetes Prevalence - A Major Growth Propeller
    • Table 1: Worldwide Prevalence of Diabetes Mellitus by Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 2: Incidence of Diabetes in Select Countries (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 3: World's Health Expenditure on Diabetes by Region (2013E): Spending (in US$ Billion) by People Diagnosed with Diabetes in the Age Group 20-79 Years to Treat Diabetes and Manage Associated Complications (includes corresponding Graph/Chart)
    • Table 4: Global Expenditure on Diabetes Treatment (2012): Spending (in US$ Billion) by Income Strata (includes corresponding Graph/Chart)
  • Rapidly Aging Demographics and Growing Incidence of Diabetes: Major Driving Factors
    • Table 5: Elderly Population (60+ Years) as a Percentage of Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 6: Global Aging Population (60+) and their Proportion of Total Population (2012) (includes corresponding Graph/Chart)
  • Increasing Obesity Levels Underpins Market Growth
    • Table 7: Global Obesity Population (2013) (includes corresponding Graph/Chart)
    • Table 8: Prevalence of Adult Obesity in Select Countries (2012) (includes corresponding Graph/Chart)
  • Developing Nations: Future Growth Opportunities
  • Increase in Healthcare Spending in Emerging Markets
    • Table 9: Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart)
  • Manufacturers Focus on Offering Products for Developing Markets
  • Near Patient Testing Gaining Ground
  • Regular HbA1c Test Keeps Heart Risk at Bay
  • Diabetes Diagnosis: Opportunities for HbA1c Testing
  • Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
  • Glycosylated Hemoglobin Tests: Paving Way for Early Stage Diabetes Diagnosis
  • Technology Developments Revolutionize Diagnostics in Diabetes Care
  • POC Testing: Positive Opportunities in Store
  • Complex Competitive Environment Prevails in POC Diagnostics Market
  • POC HbA1c Tests: Significant Advantages over Lab Tests
  • Major Testing Methods in POC HbA1c Tests
  • Immunoassays
  • Boronate Affinity Chromatography
  • Micro-Optical Detection Methods
    • Select HbA1c POC Tests in the Market - A Comparison
  • Home Monitoring: Laced with Accuracy Concerns
  • Glycated Albumin - A Potential Threat to HbA1c?
  • Higher Levels of Glycosylated Hemoglobin Increases Risk of Death
  • Non-Invasive Glucose Meters and CBGM Devices Threatens HbA1c Market
  • ESC and ADA Release Revised Guidelines for HbA1c Testing
  • Competitive Landscape
    • Table 10: Leading Players in the Global HbA1c Reagent Market (2012): Percentage Breakdown of Revenues for Bayer Diabetes Care, Siemens, and Others (includes corresponding Graph/Chart)

2. DIABETES - A BRIEF PROFILE OF THE DISEASE

  • What Causes Diabetes?
  • Types of Diabetes
  • Major Types of Diabetes
  • Likely Complications
  • Nephropathy (Kidney Disease)
  • Diabetic Neuropathy (Nerve Damage)
  • Retinopathy (Damage to the Eye and Blindness)
  • Poor Healing of Infections and Wounds
  • Impotence in Men
  • Periodontal Disease
  • Cardiovascular Disease
    • Interpreting the A1c Range
    • Blood Glucose Level Guidelines in the US
  • A Glance at Key Diabetes Statistics
    • Table 11: World Diabetes and Population Statistics (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 12: World Diabetes and Population Statistics (in Million) by Region (2013E & 2035P) - Breakdown by Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific (includes corresponding Graph/Chart)
  • Prevalence of Diabetes in Various Parts of the World
    • Table 13: Global Prevalence of Diabetes Mellitus (in Million) by Gender (2013E) - Breakdown by Region for Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific (includes corresponding Graph/Chart)
    • Table 14: Global Prevalence of Diabetes Mellitus (in Million) by Age Group (2013) - Breakdown by Region for Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific Region (includes corresponding Graph/Chart)
    • Table 15: World Diabetes Market (2013 & 2035): Top 10 Regions with Highest Number of People Diagnosed with Diabetes (in Million) in Age Group 20-79 years (includes corresponding Graph/Chart)
    • Table 16: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region (2013E) (includes corresponding Graph/Chart)
    • Table 17: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (2013E) (includes corresponding Graph/Chart)
  • Therapeutic Options for Diabetes
  • Oral Medications for Type 2 Diabetes
  • Side Effects of Insulin Therapy
  • Maintaining A1c Test Result Below 7%
  • Common Diabetes Management Practices

3. PRODUCT OVERVIEW

  • Hemoglobin - A Brief
  • Hemoglobin A1c- Description
  • HbA1c Monitoring
  • What is A1c?
    • 1. HbA1c Laboratory Testing
    • 2. HbA1c Point of Care Testing & Self-Monitoring
  • Hemoglobin A1c (HbA1c) Test
  • Interpreting HbA1c Test Readings
  • Result of Hemoglobin A1c Test
  • Clinical Use of A1c Testing
  • Advantages of A1c Assessment & Interpretation
  • Risks Associated with HbA1c Testing
  • Methods of Measurement for Glycohemoglobin
  • Why Opt for HbA1c Testing?
  • The Diabetes Control & Complications Trial (DCCT)
  • The Kumamoto and UK Prospective Studies
  • Glycemia Tests Used in Monitoring Diabetes
    • Urine Glucose Testing
    • Glycated Protein Testing
    • Table 18: Relation Between A1c Level and Mean Plasma Glucose Levels
  • HbA1c Test Types
  • HbA1c Laboratory Testing
    • Analytical Techniques Used for Quantifying HbA1c in Labs
    • Standardization of HbA1c Results
    • Table 19: CAP Accuracy Grading for HbA1c Measurements (2007-2013)
      • Select Laboratory-based HbA1c Testing Products/Analyzers
  • HbA1c Point of Care Testing & Self-Monitoring
    • Select Point of Care HbA1c Testing Products/ Analyzers
  • Standardization of Glycated Hemoglobin Testing
  • NGSP Standardization of HbA1c
  • IFCC Standardization of HbA1c
  • HbA1c Reporting
    • A1c (%) and Corresponding eAG Number (in mg/dl or mmol/l)

4. PRODUCT APPROVALS/INTRODUCTIONS

  • Piramal Enterprises Unveils Instant QDx Range of Diagnostic Devices
  • Roche Launches Cobas B 101 System for Managing Metabolic Syndrome
  • Convergys(r) Launches POC HbA1c Analyzer
  • Sanofi Showcases MyStar Extra(r) Self-Monitoring Meter
  • Roche Unveils New HbA1c Test for Diagnosis of Diabetes
  • Erba Mannheim Unveils New Hb-Vario HPLC System
  • EKF Launches Quo-Test POC HbA1c Analyzer
  • Roche Receives FDA Approval for COBAS INTEGRA 800 Tina-quant HbA1cDx Assay
  • Beckman Coulter Gets FDA Clearance for Hemoglobin A1c Assay Tests
  • Pointe Scientific Launches A1c Automated Assay for Beckman DXC 600 Analyser
  • Dynacare Upgrades Hematology Software in Hemoglobin A1C Testing
  • Tosoh Bioscience Introduces GX Glycohemoglobin Analyzer
  • Siemens Secures CE Marking for DCA HbA1c Test Kit
  • EKF Obtains CE Mark for Quo-Lab POC HbA1c Analyser
  • Streck Launches A1c-Cellular Linearity Verification Material
  • Abbott Obtains CE Marking for ARCHITECT HbA1c (IA) Fully Automated Assay
  • Tosoh Bioscience Develops ST AIA-PACK HbA1c Assay
  • Trinity Obtains FDA Approval for Premier Hb9210 HbA1c Device
  • Siemens Launches Fortified Version of DCA Vantage Analyzer
  • Tosoh Launches New Assay on its AIA-600II and AIA-360 Analyzers

5. RECENT INDUSTRY ACTIVITY

  • Quest Diagnostics Sells HemoCue Business to Radiometer
  • Techne Takes Over Bionostics
  • Express Diagnostics Takes Over Eveia Medical
  • BioHermes Enters into Agreement to Acquire HbA1c Technology from Scripps Laboratories
  • HemoCue America Inks 5-Year Agreement with ARC
  • Bio-Rad Laboratories Inks Development Agreement with Inpeco
  • Danaher Acquires Beckman Coulter
  • Alere Purchases Additional Shares of Axis-Shield
  • EKF Diagnostics Inaugurates New Manufacturing Plant in the UK
  • MinuteClinic Signs Agreement with Axis-Shield
  • Trinity Inks Distribution Agreement with Menarini for Premier Hb9210

6. FOCUS ON SELECT PLAYERS

  • Abbott Laboratories (US)
  • ARKRAY, Inc. (Japan)
  • Axis-Shield plc (UK)
  • Bayer Healthcare Diabetes Care (US)
  • Beckman Coulter, Inc. (US)
  • Bio-Rad Laboratories Inc (US)
  • Diazyme Laboratories Inc. (US)
  • EKF Diagnostics Holdings Plc (UK)
  • HEMOCUE(r) AB (Sweden)
  • Infopia Co. Ltd. (South Korea)
  • Menarini Diagnostics Ltd. (UK)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare Diagnostics (Germany)
  • Tosoh Bioscience, Inc (US)
  • Trinity Biotech plc (Ireland)

7. GLOBAL MARKET PERSPECTIVE

    • Table 20: World Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 22: World 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 23: World Recent Past, Current & Future Analysis for Laboratory-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Laboratory-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 25: World 15-Year Perspective for Laboratory- based HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 28: World 15-Year Perspective for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • HbA1c - Increasingly Moving into Physician's Office
    • HbA1c Testing for Diabetes Detection Gains Support
      • ADA Recommends HbA1c Test for Diabetes Diagnosis
      • ADA Recommends New Guidelines for HbA1c Testing for Certain Patients
      • Rising Inclination towards CLIA-Waived Tests
      • Need for Further Stringency in Requirements Arises
    • Healthcare Reform Legislation: Impact on Diabetes Diagnostics
    • US Near Patient HbA1c Testing - A Highly Consolidated Market
    • Table 29: Leading Players in the US Near Patient HbA1c Testing Market (2013): Percentage Share Breakdown of Revenues for Siemens, Axis-Shield, and Others (includes corresponding Graph/Chart)
    • Diabetes Statistics in North America and Caribbean Region
    • Table 30: North American and Caribbean Regional Population and Diabetes Prevalence Statistics (2013E) - Top Regions with High Prevalence of Diabetes by Age Group and Gender (includes corresponding Graph/Chart)
    • Table 31: Diabetes and Population Statistics in North America and Caribbean Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Diabetes Statistics in the US - An Overview
      • Age Factor
    • Table 32: Number of Diabetics by Gender in the US (2013E) (in '000s) (includes corresponding Graph/Chart)
    • Table 33: Number of Diabetics in the US by Age Group (2013E) (in '000s) (includes corresponding Graph/Chart)
      • Prevalence by Race/Ethnicity
    • Table 34: US Market for Diabetes (2012): Percentage Breakdown of Prevalence by Race/Ethnicity - Non-Hispanic Blacks and Non-Hispanic Whites (includes corresponding Graph/Chart)
      • Mean HbA1c Scores at National Level
      • Economic Burden of Diabetes in the US
    • Table 35: Direct Medical Expenditure on Diabetes Management in the US (2012): Percentage Share Breakdown of Costs Incurred by Component (includes corresponding Graph/Chart)
    • Table 36: Indirect Costs of Diabetes in the US (2012): Percentage Share Breakdown by Component (includes corresponding Graph/Chart)
    • Product Approvals/Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 37: US Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 38: US Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011(includes corresponding Graph/Chart)
    • Table 39: US 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics in Canada
    • Table 40: Adult Diabetes Population by Gender in Canada (2013) (In '000s) (includes corresponding Graph/Chart)
    • Table 41: Adult Diabetes Population by Age Group in Canada (2013) (In '000s) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 42: Canadian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Canadian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 44: Canadian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • ARKRAY, Inc. - A Major Player
  • B. Market Analytics
    • Table 45: Japanese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 46: Japanese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 47: Japanese 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Positive Outlook for Diabetes Diagnostics Market in Europe
    • Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption
    • Competitive Environment
    • Table 48: Leading Players in the European Point-of-Care HbA1c Tests Market (2011): Percentage Share Breakdown of Revenues for Axis-Shield, Hemocue, Siemens Healthcare Diagnostics, and Others (includes corresponding Graph/Chart)
    • A Glance at Key Diabetes Statistics in Europe
    • Table 49: Diabetes and Population Statistics in Europe (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 50: European Population and Diabetes Prevalence Statistics (2013E) - Select Regions with High Prevalence of Diabetes for Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 51: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 52: European Historic Review for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 53: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 54: European Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 55: European 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)
    • Table 56: European 15-Year Perspective for HbA1c Monitoring by Segment -Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 57: French Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 58: French Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 59: French 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Product Approvals/Introductions
    • Siemens Healthcare Diagnostics - A Key Player
  • B. Market Analytics
    • Table 60: German Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 61: German Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 62: German 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 63: Italian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Italian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 65: Italian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics & Management - An Insight
      • Rising Obesity Cases - Increased Risk of Diabetes
      • Type 1 Diabetes in Children
    • Table 66: Number of Type 1 Diabetics Per 100,000 Children in Select Countries (2011) (includes corresponding Graph/Chart)
    • NHS England Launches Action for Diabetes Plan
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 67: UK Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 68: UK Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 69: UK 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
    • Product Launch
  • B. Market Analytics
    • Table 70: Spanish Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 71: Spanish Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 72: Spanish 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 73: Russian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 74: Russian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 75: Russian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 76: Rest of Europe Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 77: Rest of Europe Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 78: Rest of Europe 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics - An Overview
    • Table 79: Diabetes and Population Statistics in Western Pacific (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 80: Western Pacific Population and Diabetes Prevalence Statistics (2013E) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
    • Table 81: Diabetes and Population Statistics in South East Asia (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 82: South East Asian Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific Historic Review for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)
    • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 88: Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Increasing Diabetes Incidence Spurs Growth in Diabetes Diagnostics Market
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 89: Chinese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Chinese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 91: Chinese 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • HbA1c Testing on Growth Spree
      • Growth Stimulants & Challenges in a Nut Shell
    • Rising Diabetes Cases - Opportunities for HbA1c Monitoring Market
    • Product Launch
  • B. Market Analytics
    • Table 92: Indian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Indian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 94: Indian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics in Australia
    • Table 95: Diabetes Population Breakdown by Age Group in Australia (2011-12) (includes corresponding Graph/Chart)
    • Infopia Co. Ltd. (South Korea) - A Major Player
  • B. Market Analytics
    • Table 96: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Rest of Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 98: Rest of Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Diabetes in Latin America - A Glance at Key Statistics
    • Table 99: Diabetes and Population Statistics in Central and South America (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 100: Central and South American Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 101: Latin American Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 102: Latin American Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 103: Latin American 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Diabetes Statistics in Africa and the Middle East
    • Table 104: African Diabetes and Population Statistics (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 105: African Population and Diabetes Prevalence Statistics (2013) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
    • Table 106: Diabetes and Population Statistics in Middle East and North Africa (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 107: Middle East and North African Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 108: Rest of World Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart)
    • Table 109: Rest of World Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart)
    • Table 110: Rest of World 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top